Regulations.gov document
Updated Letter from FDA CFSAN to Burdock Group Consultants
Other · FDA-2017-Q-0807 · posted Mar 24, 2021
Key facts
| Document ID | FDA-2017-Q-0807-0170 |
|---|---|
| Title | Updated Letter from FDA CFSAN to Burdock Group Consultants |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2017-Q-0807 |
| Posted | Mar 24, 2021 |
| Comment period opens | Mar 24, 2021 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: